Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection

By rosaguerrero • July 29, 2022

Kelesidis T, Mantzoros CS. Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection. Metabolism. 2022 Jul 25;134:155267. doi: 10.1016/j.metabol.2022.155267. Epub ahead of print. PMID: 35901934; PMCID: PMC9313531.

Tags: Infectious Diseases, Publications

Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the[...]

Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE

Kileel EM, Malvestutto CD, Zanni MV, Davies-Smith E, Fichtenbaum CJ, Lake JE, Lo J, Aberg JA, Martinez E, Patel K, Bloomfield GS, Chu SM, Awwad[...]

Discovery and cryoEM structure of FPM13, a periplasmic metalloprotein unique to Francisella

Clemens DL, Lee BY, Liu X, Zhou ZH, Horwitz MA. Discovery and cryoEM structure of FPM13, a periplasmic metalloprotein unique to Francisella. PLoS Pathog. 2026[...]